Torrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals has called a court-convened meeting of its equity shareholders for Tuesday, April 28, 2026 at 10:00 a.m. IST, to be held via video conferencing, following an order dated March 23, 2026 from the NCLT Ahmedabad Bench. The sole agenda is to consider and approve the proposed Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) into Torrent Pharmaceuticals under Sections 230-232 of the Companies Act, 2013. Torrent has already acquired about 7.83 crore equity shares of JB Pharma from Tau Investment Holdings and employee shareholders, and has completed the mandatory open offer, picking up 1,317 additional shares from the public. Remote e-voting runs from April 24, 2026 (9:00 a.m.) to April 27, 2026 (5:00 p.m.), with April 21, 2026 as the cut-off date, and the resolution requires majority in number representing three-fourths in value of voting shareholders to pass. The share exchange ratio has been jointly determined by Ernst & Young Merchant Banking Services and BDO Valuation Advisory, with fairness opinions from Axis Capital and ICICI Securities.
Torrent Pharma shareholders must vote on the merger by April 28, 2026. If approved by the requisite majority and subsequently sanctioned by the NCLT, JB Pharma will be absorbed into Torrent, creating a significantly larger pharmaceutical company. The merger could expand Torrent's product portfolio, market reach and earnings base, though it also depends on the final share swap ratio and post-merger integration outcomes.